Tag: malignant breast neoplasm

Support for Chemo in Some Older Women With Breast Cancer, Comorbid Conditions

NEW YORK (Reuters Health) – Adjuvant chemotherapy can improve overall survival in elderly women with node-positive, estrogen receptor-positive breast cancer and multiple comorbidities, according a...

Does Obesity Reduce Drug Efficacy in Breast Cancer?

Obesity has been shown to have an impact on the risk of developing breast cancer and on prognosis. A new study suggests that it may...

FDA Approves Olaparib for Certain Metastatic Prostate Cancers

The US Food and Drug Administration approved olaparib (Lynparza, AstraZeneca) for deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant...

HRT Update Regarding Breast Cancer Risk Advised in EU

In concluding their review of hormone replacement therapy (HRT) and the associated risk of breast cancer, the EU Pharmacovigilance Risk Assessment Committee (PRAC) has recommended...

First PARP Inhibitor Approved for Metastatic Prostate Cancer

A completely new approach to the treatment of prostate cancer is now available to clinicians through the approval of the first PARP inhibitor for use...

Adding a Blood Test to Screening May Improve Cancer Detection

A minimally invasive multicancer blood test used with standard-of-care screening is safe, effective, and feasible for use in routine clinical care, according to interim findings...

Will Coronavirus Restrictions Lead to More Advanced Cancers?

What your doctor is reading on Medscape.com: APRIL 22, 2020 — My pathology lab once faced a daily flood of colon polyps, pap smears,...

Cognitive Decline With Endocrine Tx for Breast Ca

Cognitive impairment seen in women with early breast cancer who undergo chemotherapy ― so-called chemobrain ― has now been reported in patients who are treated...

‘Encouraging’ Results With Pre-Op Therapy for DCIS

First-of-its-kind findings suggest that hormonal therapy could be the primary treatment instead of surgery for women who are diagnosed with a precursor of breast cancer,...

FDA Approves First New Drug With International Group

The US Food and Drug Administration today approved the oral therapy tucatinib (Tukysa, Seattle Genetics) for the treatment of advanced HER2-positive breast cancer. This is...

COVID-19 Breast Cancer Patient Triage Guidelines (CPBCC)

What your doctor is reading on Medscape.com: APRIL 08, 2020 — The guideline on COVID-19–related triage of patients with breast cancer was released on...

Home-Based Chemo Skyrockets at One US Center

In the fall of 2019, the University of Pennsylvania in Philadelphia started a pilot program of home-based chemotherapy for two treatment regimens (one via infusion...

Differences in How Men and Women Respond to Radiotherapy?

Men and women who undergo treatment for cancer react differently to radiotherapy (RT), according to evidence drawn from a literature review. The study found a...

Younger Gynecologic Cancer Patients at Risk for Early Bone Loss

Younger women treated for uterine or ovarian cancer are at increased risk for decreased bone mineral density and osteoporosis, especially in the first year after...